Mother of 5-year-old girl killed in Franklin crash by accused drunk driver has also died, DA says
A vigil is planned for the mother of a 5-year-old girl killed in a crash by an accused drunk driver in Franklin over Memorial Day weekend who has also died.
Minaben Patel, 38, of Franklin, has died days after the May 24 crash that killed her daughter, Krisha Patel, 5, according to the district attorney and a Facebook post by the SAFE Coalition on Tuesday afternoon.
'The Norfolk District Attorney's Office and the Franklin Police Department are saddened by the loss to Minaben's family and we extend our heartfelt condolences,' Norfolk District Attorney Michael Morrissey and Franklin Police Chief Thomas Lynch said in a statement Tuesday.
A vigil for Minaben Patel is planned for 6 p.m. Thursday at the crash site on Grove Street in Franklin, The SAFE Coalition, a Franklin-based nonprofit group, said in its Facebook post.
Another vigil was held for her daughter, Krisha Patel, at the site last Wednesday.
'We would like to share, through the families wishes, that Minaben Patel, mother of sweet Krisha, has passed away,' the SAFE Coalition said in its post.
'Minaben's family is again deeply thankful for all the love and support shared over the last week,' the group said. 'They invite the community to honor this amazing Mother, Wife, Family Member and friend this Thursday for a service of remembrance.'
The driver accused in the fatal crash, James Blanchard, 21, of Franklin, was ordered held on $250,000 cash bail following his arraignment on May 27. A not guilty plea was entered on Blanchard's behalf.
He is charged with motor vehicle homicide while driving negligently and under the influence of alcohol, three counts of driving under the influence of alcohol and causing serious bodily injury, negligent driving, driving a motor vehicle with an open container of alcohol, and marked lanes violation, according to Norfolk District Attorney Michael Morrissey.
It was immediately unclear Tuesday if Blanchard would face additional charges in the case. Boston 25 has reached out to Morrissey's office for comment.
During his arraignment, prosecutor Christopher Meade said Blanchard told police he had two beers while at a landscaping job on Saturday, May 24 after working that morning at his job as a mechanic.
When he left his landscaping job, he opened a 1.75 liter bottle of Tito's vodka. He began drinking straight out of the bottle and drove home in his truck, Meade said during the arraignment in Wrentham District Court.
Investigators later found a second, empty 1.75 liter bottle of Tito's in his truck that Blanchard told police was 'from the night before,' Meade said.
While driving home around 6:22 p.m. Saturday, May 24, Blanchard crashed into a Honda Accord carrying a family of four on Grove Street in Franklin, Meade said. They were going to Blackstone for a family birthday party.
The 5-year-old girl died following the crash, Meade said.
Her mother and brother were taken to a local hospital in critical condition. The brother's condition was not known on Tuesday.
Her father, the driver of the Honda, was treated and released.
Defense attorney Timothy Flaherty had asked the court during Blanchard's arraignment to impose a lesser amount of $10,000 cash bail, with conditions for his release to include electronic monitoring and that he enter an alcohol rehabilitation center.
'It's probably the right place for this young man at this time,' Flaherty said during the arraignment. 'It's a significant case but significant penalties. But I can tell the court that this young man is not a risk of flight.'
An autopsy will be performed to determine a cause of Minaben Patel's death, the district attorney said.
Meanwhile, services were held for Krisha Patel on May 31, according to the girl's obituary.
'Our hearts are broken as we say goodbye to such a precious little soul. In her short time with us, she filled the world with laughter, wonder, and love,' her obituary states. 'Her smile could brighten the darkest day, and her kind heart touched everyone she met.'
'Though her time here was far too brief, her spirit will forever live on in the hearts of all who loved her,' her obituary states. 'We will carry her memory with us always - like a beautiful, shining star in the sky. May she rest peacefully, wrapped in love and light.'
The crash remains under investigation by Franklin Police, the Norfolk District Attorney's Office and the Massachusetts State Police Collision Analysis and Reconstruction Section.
This is a developing story. Check back for updates as more information becomes available.
Download the FREE Boston 25 News app for breaking news alerts.
Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Sydnexis Announces European Commission Approval of SYD-101, the First and Only Pharmaceutical Treatment for Slowing the Progression of Pediatric Myopia
Exclusive-Licensing Partner Santen Will Commercialize SYD-101 Under the Brand Name Ryjunea® in the European Union DEL MAR, Calif., June 05, 2025--(BUSINESS WIRE)--Sydnexis, Inc., ( a pre-commercial stage biopharmaceutical company today announced that the European Commission (EC) has granted marketing authorization for SYD-101, the company's proprietary low-dose atropine formulation, for slowing the progression of pediatric myopia. As the first and only approved pharmaceutical treatment option to treat myopia progression in EU countries, this approval marks a significant advancement in pediatric eye care. The approval is backed by data from the STAR study, Sydnexis' pivotal Phase 3 clinical trial evaluating its proprietary low-dose atropine formulation to slow the progression of pediatric myopia and the risk of associated co-morbidities in children 3 to 14 years old at treatment initiation. "This marks a significant milestone for Sydnexis and, most importantly, for pediatric patients with progressive myopia, their families, and physicians as the first and only approved pharmaceutical treatment option in Europe," said Perry Sternberg, Chief Executive Officer of Sydnexis. "This approval is an endorsement of the potential benefit SYD-101 can provide to millions of patients globally and reinforces the critical importance of early intervention." The marketing approval from the EC follows the recent positive opinion from the Committee for Medicinal Products for Human Use (CHMP). Santen, a Japan-based company specialized in eye health, offering innovative products and services in over 60 countries worldwide, licensed the rights from Sydnexis to commercialize SYD-101 in the regions of Europe, Middle East, and Africa (EMEA) and will launch SYD-101 under the brand name Ryjunea. "The EU approval of SYD-101 is a recognition of the compelling safety and efficacy data generated from our landmark STAR study," said Patrick Johnson, Ph.D., President of Sydnexis. "This validates the potential benefit that SYD-101 can provide to pediatric myopes in Europe and we are excited about our continued interactions with the Food and Drug Administration (FDA) leading up to our October 23 PDUFA date." Myopia is the most common eye disease in children, impacting approximately one-third of children and adolescents worldwide. By 2050, global prevalence is projected to increase and affect more than 740 million children and adolescents and 5 billion people in total. Once considered a benign refractive condition, even at low levels, myopia is now associated with many serious irreversible sight-threatening co-morbidities later in life. "As a Pediatric Ophthalmologist with a rapidly growing number of myopia patients around the world, the EU approval of SYD-101 is truly exciting and it provides an important new tool for physicians to combat this global epidemic," said Dr. Donny Suh, Gavin Herbert Eye Institute, University of California at Irvine. "The benefits of low-dose atropine have long been recognized in the eye care community, but we now finally have an approved and thoroughly vetted treatment option. This marks a new era in our ability to slow the progression of myopia and protect the vision of millions of children worldwide." About Sydnexis, Inc.: Founded in 2014, Sydnexis, Inc. ( is a privately held, pre-commercial stage biopharmaceutical company based in San Diego, California. Sydnexis recently completed its three-year primary endpoint in the pivotal Phase 3 clinical trial evaluating its proprietary low-dose atropine formulation to slow progression of pediatric myopia and the risk of associated co-morbidities. The Phase 3 clinical trial is now completing the fourth-year randomized withdrawal for exploratory endpoints and third year results will be announced upon completion of the fourth year of the study. The company is venture-backed by four major investors: Visionary Ventures, RA Capital, Longitude Capital, and Bluestem Capital. View source version on Contacts For media inquiries, please contact: media@
Yahoo
an hour ago
- Yahoo
Corrupt Edinburgh NHS manager jailed for eight years over £6m contracts
Four men have been jailed for a total of 29 years over the awarding of NHS contracts worth £6million. Alan Hush, 68, Adam Sharoudi, 41, Gavin Brown, 48, and Gavin Cox, 60, were convicted by a jury following an investigation at health boards across Scotland. Hush, telecommunications manager at NHS Lothian and then NHS Scotland's video conferencing manager, was sentenced to eight years in jail. READ MORE: Edinburgh man's touching tribute for best pal after his unexpected death at 38 READ MORE: 'Maggots burst from tin of tuna I was about to feed my baby - I can never eat touch it again' Sharoudi and Brown, directors of Ayrshire-based telecommunications firm Oricom Ltd, were imprisoned for eight years and seven years respectively. Cox, who held the post of head of IT and infrastructure at NHS Lanarkshire, will spend six years in prison. Sineidin Corrins, Deputy Procurator Fiscal for Specialist Casework at the Crown Office and Procurator Fiscal Service (COPFS), said: 'This is an outstanding result for justice in Scotland. 'As prosecutors, we have shown an unwavering commitment to pursuing and investigating this matter. This was a betrayal of public trust. 'These four men colluded to create a sophisticated criminal scheme. The public will rightly be shocked by the scale of their criminality. The scale of this offending against our public health service is particularly egregious. 'The systematic abuse of position by public officials, who accepted inappropriate benefits including cash, holidays and entertainment in exchange for contract advantages, strikes at the heart of public trust. 'It serves as a reminder that procurement processes exist to ensure fair competition and value for public money. When these processes are corrupted, all of society bears the cost. 'The prosecutorial journey has been complex and demanding. It required forensic examination of thousands of documents, hundreds of witness statements, and detailed financial analyses to establish the full extent of this criminal activity. Sign up for Edinburgh Live newsletters for more headlines straight to your inbox 'The digital evidence, particularly text messages and emails exchanged between the accused, proved pivotal in exposing the true nature of these arrangements. 'This was a meticulous investigation and one which reflects the enduring partnership working between specialist Crown Office prosecutors, NHS Counter Fraud Services and Police Scotland who worked tirelessly over many years. 'Their unflinching dedication to serving the interests of justice, regardless of complexity or duration, deserves recognition. 'The Crown Office and Procurator Fiscal Service has worked closely with these specialist reporting agencies to ensure justice has been served. 'This case demonstrates clearly that those who indulge in corrupt practices for their own personal gain will be brought to book regardless of the time it takes to bring offenders to justice. Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. 'The Proceeds of Crime proceedings that will follow demonstrate our ongoing commitment to ensuring that crime does not pay and that illicitly obtained funds are recovered where possible.' All four individuals will now be subject to confiscation action under Proceeds of Crime legislation to recover monies illegally obtained. Brown and Sharoudi were also banned from being company directors for 10 years.
Yahoo
an hour ago
- Yahoo
Four men jailed over ‘egregious' NHS bribery and corruption offences
Four men convicted of bribery and corrupt practices over the awarding of NHS contracts worth £6 million have been jailed. Alan Hush, 68, Adam Sharoudi, 41, Gavin Brown, 48, and Gavin Cox, 60, were convicted following a trial at the High Court in Glasgow which followed an investigation at health boards across Scotland. The offences, which took place between 2010 and 2017, included bribery, corruption, and other offences under the Proceeds of Crime Act. Hush and Sharoudi were additionally convicted of charges of fraud. Sharoudi and Brown, directors of Ayrshire-based telecommunications firm Oricom Ltd, were jailed for eight years and seven years respectively when they were sentenced at the court on Thursday, the Crown Office and Procurator Fiscal Service (COPFS) said. Hush, who was telecommunications manager at NHS Lothian, was sentenced to eight years in jail, while Cox, who was head of IT and infrastructure at NHS Lanarkshire, was jailed for six years. In a sentencing statement later published online, Lord Arthurson said: 'The public are entitled to expect that their fellow citizens will not seek to subvert public officials in the diligent exercise of their duties, and public officials in their turn should know that succumbing to bribery will result in the handing down by the court of immediate and significant custodial terms. 'The reach and character of the corruption and in particular the corrupt relationships engaged in by all of you, when considered as a whole, was on a grand scale.' The trial at the High Court in Glasgow lasted 65 days. Sineidin Corrins, deputy procurator fiscal for specialist casework at COPFS, said: 'This is an outstanding result for justice in Scotland. 'As prosecutors, we have shown an unwavering commitment to pursuing and investigating this matter. This was a betrayal of public trust. 'These four men colluded to create a sophisticated criminal scheme. The public will rightly be shocked by the scale of their criminality. At the High Court in Glasgow, Lord Arthurson sentenced Alan Hush, Gavin Cox, Adam Sharoudi & Gavin Brown to imprisonment for bribery and proceeds of crime offences. Hush received 8 years' imprisonment, Cox 6 years, Sharoudi 8 years, and Brown 7 years. — Judges Scotland (@JudgesScotland) June 5, 2025 'The scale of this offending against our public health service is particularly egregious. 'The systematic abuse of position by public officials, who accepted inappropriate benefits including cash, holidays and entertainment in exchange for contract advantages, strikes at the heart of public trust. 'It serves as a reminder that procurement processes exist to ensure fair competition and value for public money. When these processes are corrupted, all of society bears the cost. 'The prosecutorial journey has been complex and demanding. It required forensic examination of thousands of documents, hundreds of witness statements, and detailed financial analyses to establish the full extent of this criminal activity. 'The digital evidence, particularly text messages and emails exchanged between the accused, proved pivotal in exposing the true nature of these arrangements. 'This was a meticulous investigation and one which reflects the enduring partnership working between specialist Crown Office prosecutors, NHS Counter Fraud Services and Police Scotland, who worked tirelessly over many years. 'Their unflinching dedication to serving the interests of justice, regardless of complexity or duration, deserves recognition.' The four men will now be subject to confiscation action under proceeds of crime legislation to recover monies illegally obtained. Brown and Sharoudi were also banned from being company directors for 10 years.
